Biogen将向北卡罗来纳州三角研究公园额外投资20亿美元

2025-07-21 19:38

Biogen (NASDAQ:BIIB) plans to invest an additional $2 billion in its manufacturing facilities at North Carolina’s Research Triangle Park (RTP), bringing its total investment in the region to around $10 billion since 1995.
The new investment will help advance its late-stage clinical pipeline. In the coming years, the biotech firm also plans to continue investing in multiple modalities and factories across its two RTP campuses.
These investments will include further expansion of the antisense oligonucleotide capabilities and infrastructure, establishing clinical and commercial multi-platform fill finish capabilities, and continuing to modernize manufacturing technologies and controls through further advanced automation and artificial intelligence.
Source: Press Release

More on Biogen